<?xml version="1.0" encoding="UTF-8"?>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99023506</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="YM268" sem="G#other_organic_compound"><w c="NN">YM268</w></cons> <w c="VBZ">increases</w> <w c="DT">the</w> <cons lex="glucose_uptake" sem="G#other_name"><w c="NN">glucose</w> <w c="NN">uptake</w></cons><w c=",">,</w> <w c="NN">cell</w> <w c="NN">differentiation</w><w c=",">,</w> <w c="CC">and</w> <cons lex="mRNA_expression" sem="G#other_name"><w c="NN">mRNA</w> <w c="NN">expression</w></cons> <w c="IN">of</w> <cons lex="glucose_transporter" sem="G#protein_complex"><w c="NN">glucose</w> <w c="NN">transporter</w></cons> <w c="IN">in</w> <cons lex="3T3-L1_adipocyte" sem="G#cell_type"><w c="NN">3T3-L1</w> <w c="NNS">adipocytes</w></cons><w c=".">.</w></sentence>
</title>
<abstract>
<sentence><w c="DT">The</w> <w c="NN">purpose</w> <w c="IN">of</w> <w c="DT">this</w> <w c="NN">study</w> <w c="VBD">was</w> <w c="TO">to</w> <w c="VB">examine</w> <w c="DT">the</w> <w c="NNS">effects</w> <w c="IN">of</w> <cons lex="bis[4-[2,4-dioxo-5-thiazolidinyl)methyl]phenyl]methane" sem="G#other_organic_compound"><w c="NN">bis[4-[2,4-dioxo-5-thiazolidinyl)methyl]phenyl]</w><w c="NN">methane</w></cons> <w c="(">(</w><cons lex="YM-268" sem="G#other_organic_compound"><w c="NN">YM-268</w></cons><w c=")">)</w><w c=",">,</w> <w c="DT">a</w> <cons lex="thiazolidinedione_derivative" sem="G#other_organic_compound"><w c="JJ">thiazolidinedione</w> <w c="NN">derivative</w></cons><w c=",">,</w> <w c="IN">on</w> <cons lex="glucose_uptake" sem="G#other_name"><w c="NN">glucose</w> <w c="NN">uptake</w></cons><w c=",">,</w> <cons lex="adipocyte_differentiation" sem="G#other_name"><cons lex="adipocyte" sem="G#cell_type"><w c="NN">adipocyte</w></cons> <w c="NN">differentiation</w></cons> <w c="IN">through</w> <cons lex="peroxisome_proliferator-activated_receptor_gamma" sem="G#protein_molecule"><w c="NN">peroxisome</w> <w c="JJ">proliferator-activated</w> <w c="NN">receptor</w> <w c="NN">gamma</w></cons><w c="(">(</w><cons lex="PPARgamma" sem="G#protein_molecule"><w c="NN">PPARgamma</w></cons><w c=")">)</w><w c=",">,</w> <w c="CC">and</w> <cons lex="phosphatidylinositol_3-kinase_(PI_3-kinase)_activity" sem="G#other_name"><cons lex="phosphatidylinositol_3-kinase" sem="G#protein_molecule"><w c="NN">phosphatidylinositol</w> <w c="NN">3-kinase</w></cons> <w c="(">(</w><cons lex="PI_3-kinase" sem="G#protein_molecule"><w c="NN">PI</w> <w c="NN">3-kinase</w></cons><w c=")">)</w> <w c="NN">activity</w></cons> <w c="IN">in</w> <cons lex="cultured_cell" sem="G#cell_line"><w c="VBN">cultured</w> <w c="NNS">cells</w></cons><w c=".">.</w></sentence>
<sentence><cons lex="YM268" sem="G#other_organic_compound"><w c="NN">YM268</w></cons> <w c="CC">and</w> <cons lex="pioglitazone" sem="G#other_organic_compound"><w c="NN">pioglitazone</w></cons> <w c="RB">dose-dependently</w> <w c="VBD">increased</w> <w c="DT">the</w> <cons lex="2-deoxyglucose_uptake" sem="G#other_name"><cons lex="2-deoxyglucose" sem="G#carbohydrate"><w c="NN">2-deoxyglucose</w></cons> <w c="NN">uptake</w></cons> <w c="IN">in</w> <cons lex="3T3-L1_cell" sem="G#cell_line"><w c="NN">3T3-L1</w> <w c="NNS">cells</w></cons><w c=".">.</w></sentence>
<sentence><cons lex="YM268" sem="G#other_organic_compound"><w c="NN">YM268</w></cons> <w c="VBD">facilitated</w> <w c="DT">the</w> <cons lex="insulin-stimulated_triglyceride_accumulation" sem="G#other_name"><w c="JJ">insulin-stimulated</w> <w c="NN">triglyceride</w> <w c="NN">accumulation</w></cons> <w c="IN">in</w> <cons lex="3T3-L1_adipocyte" sem="G#cell_type"><w c="NN">3T3-L1</w> <w c="NNS">adipocytes</w></cons> <w c="CC">and</w> <w c="VBD">increased</w> <w c="DT">the</w> <cons lex="mRNA_expression" sem="G#other_name"><w c="NN">mRNA</w> <w c="NN">expression</w></cons> <w c="IN">of</w> <cons lex="fatty_acid-binding_protein" sem="G#protein_molecule"><w c="JJ">fatty</w> <w c="JJ">acid-binding</w> <w c="NN">protein</w></cons><w c=".">.</w></sentence>
<sentence><cons lex="YM268" sem="G#other_organic_compound"><w c="NN">YM268</w></cons><w c=",">,</w> <w c="IN">with</w> <w c="CC">and</w> <w c="IN">without</w> <cons lex="insulin" sem="G#peptide"><w c="NN">insulin</w></cons><w c=",">,</w> <w c="VBD">increased</w> <w c="DT">the</w> <cons lex="mRNA_expression" sem="G#other_name"><w c="NN">mRNA</w> <w c="NN">expression</w></cons> <w c="IN">of</w> <cons lex="glucose_transporter" sem="G#protein_complex"><w c="NN">glucose</w> <w c="NN">transporter</w></cons> <w c="NNS">isoforms</w> <w c="JJ">such</w> <w c="IN">as</w> <cons lex="GLUT1" sem="G#protein_complex"><w c="NN">GLUT1</w></cons> <w c="CC">and</w> <cons lex="GLUT4" sem="G#protein_complex"><w c="NN">GLUT4</w></cons><w c=",">,</w> <w c="VBG">indicating</w> <w c="NN">enhancement</w> <w c="IN">of</w> <cons lex="adipocyte_differentiation" sem="G#other_name"><cons lex="adipocyte" sem="G#cell_type"><w c="NN">adipocyte</w></cons> <w c="NN">differentiation</w></cons><w c=".">.</w></sentence>
<sentence><w c="RB">Additionally</w><w c=",">,</w> <cons lex="YM268" sem="G#other_organic_compound"><w c="NN">YM268</w></cons> <w c="CC">and</w> <cons lex="pioglitazone" sem="G#other_organic_compound"><w c="NN">pioglitazone</w></cons> <w c="VBD">showed</w> <w c="NN">activity</w> <w c="IN">of</w> <w c="DT">the</w> <cons lex="PPARgamma_ligand" sem="G#protein_molecule"><cons lex="PPARgamma" sem="G#protein_molecule"><w c="NN">PPARgamma</w></cons> <w c="NN">ligand</w></cons><w c=",">,</w> <w c="DT">a</w> <w c="NN">member</w> <w c="IN">of</w> <w c="DT">the</w> <cons lex="nuclear_receptor_superfamily" sem="G#protein_family_or_group"><w c="JJ">nuclear</w> <w c="NN">receptor</w> <w c="NN">superfamily</w></cons> <w c="JJ">responsible</w> <w c="IN">for</w> <cons lex="adipogenesis" sem="G#other_name"><w c="NN">adipogenesis</w></cons><w c=".">.</w></sentence>
<sentence><w c="TO">To</w> <w c="VB">examine</w> <w c="DT">the</w> <w c="JJ">possible</w> <w c="NN">involvement</w> <w c="IN">of</w> <w c="DT">the</w> <w c="VBN">increased</w> <w c="NN">activity</w> <w c="IN">of</w> <cons lex="PI_3-kinase" sem="G#protein_molecule"><w c="NN">PI</w> <w c="NN">3-kinase</w></cons> <w c="IN">in</w> <cons lex="YM268" sem="G#other_organic_compound"><w c="*">YM268</w></cons><w c="JJ">-stimulated</w> <cons lex="glucose_uptake" sem="G#other_name"><w c="NN">glucose</w> <w c="NN">uptake</w></cons><w c=",">,</w> <w c="DT">the</w> <cons lex="enzyme_activity" sem="G#other_name"><w c="NN">enzyme</w> <w c="NN">activity</w></cons> <w c="VBD">was</w> <w c="VBN">estimated</w> <w c="IN">by</w> <w c="VBG">measuring</w> <w c="DT">the</w> <cons lex="phosphatidylinositol-3,4,5-trisphosphate" sem="G#other_organic_compound"><w c="NN">phosphatidylinositol-3,4,5-trisphosphate</w></cons> <w c="(">(</w><cons lex="PI-3,4,5-P3" sem="G#other_organic_compound"><w c="NN">PI-3,4,5-P3</w></cons><w c=")">)</w> <w c="NN">concentration</w> <w c="IN">in</w> <cons lex="human_monocytic_cell" sem="G#cell_type"><w c="JJ">human</w> <w c="JJ">monocytic</w> <w c="NNS">cells</w></cons><w c=".">.</w></sentence>
<sentence><w c="NN">Insulin</w> <w c="RB">dose-dependently</w> <w c="VBD">increased</w> <w c="DT">the</w> <cons lex="PI-3,4,5-P3_production" sem="G#other_name"><cons lex="PI-3,4,5-P3" sem="G#other_organic_compound"><w c="NN">PI-3,4,5-P3</w></cons> <w c="NN">production</w></cons> <w c="CC">but</w> <cons lex="YM268" sem="G#other_organic_compound"><w c="NN">YM268</w></cons> <w c="VBD">had</w> <w c="DT">no</w> <w c="JJ">significant</w> <w c="NN">effect</w> <w c="IN">on</w> <w c="DT">the</w> <cons lex="(AND insulin-dependent_PI_3-kinase_activation insulin-independent_PI_3-kinase_activation)" sem="(AND G#other_name G#other_name)"><cons lex="insulin*"><w c="*">insulin</w></cons><cons lex="*-dependent*"><w c="JJ">-dependent</w></cons> <w c="CC">and</w> <cons lex="*-independent*"><w c="JJ">-independent</w></cons> <cons lex="*PI_3-kinase_activation"><w c="NN">PI</w> <w c="NN">3-kinase</w> <w c="NN">activation</w></cons></cons><w c=".">.</w></sentence>
<sentence><w c="DT">These</w> <w c="NNS">results</w> <w c="VBP">indicate</w> <w c="IN">that</w> <w c="DT">the</w> <w c="NN">mechanism</w> <w c="IN">by</w> <w c="WDT">which</w> <cons lex="YM268" sem="G#other_organic_compound"><w c="NN">YM268</w></cons> <w c="VBD">increased</w> <cons lex="glucose_uptake" sem="G#other_name"><w c="NN">glucose</w> <w c="NN">uptake</w></cons><w c=",">,</w> <w c="MD">may</w> <w c="VB">be</w> <w c="VBN">accounted</w> <w c="IN">for</w> <w c="IN">in</w> <w c="NN">part</w> <w c="IN">by</w> <w c="DT">the</w> <w c="NN">enhancement</w> <w c="IN">of</w> <cons lex="GLUT1" sem="G#protein_complex"><w c="NN">GLUT1</w></cons> <w c="CC">and</w> <cons lex="GLUT4" sem="G#protein_complex"><w c="NN">GLUT4</w></cons> <w c="NN">expression</w> <w c="IN">through</w> <cons lex="PPARgamma_activation" sem="G#other_name"><cons lex="PPARgamma" sem="G#protein_molecule"><w c="NN">PPARgamma</w></cons> <w c="NN">activation</w></cons><w c=".">.</w></sentence>
</abstract>
</article>
